Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: Savolitinib
Study Title: A study to learn how savolitinib acts in the bodies of healthy men when taken with and without rifampicin
Thank you!
Thank you to the participants who took part in the clinical study for the study drug savolitinib. AstraZeneca AB sponsored this study and thinks it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results.
If you participated in the study and have questions about the results, please speak with the study doctor or staff at your study site.
Who took part in the study?
The researchers asked for the help of healthy men. The participants in this study were 21 to 58 years old when they joined.
The study included 20 participants in the United States.